litlas
ログインアカウント作成

Katalin Karikó

1987–2023 年に発表

61
論文数
24,829
被引用数
54
h 指数
61
i10 指数

被引用数

Katalin Karikó の年別被引用数1988 年: 被引用 3 件1989 年: 被引用 3 件1990 年: 被引用 1 件1991 年: 被引用 5 件1992 年: 被引用 1 件1993 年: 被引用 3 件1994 年: 被引用 7 件1995 年: 被引用 12 件1996 年: 被引用 13 件1997 年: 被引用 7 件1998 年: 被引用 9 件1999 年: 被引用 5 件2000 年: 被引用 1 件2001 年: 被引用 9 件2002 年: 被引用 16 件2003 年: 被引用 31 件2004 年: 被引用 55 件2005 年: 被引用 103 件2006 年: 被引用 93 件2007 年: 被引用 72 件2008 年: 被引用 101 件2009 年: 被引用 117 件2010 年: 被引用 77 件2011 年: 被引用 128 件2012 年: 被引用 145 件2013 年: 被引用 130 件2014 年: 被引用 112 件2015 年: 被引用 162 件2016 年: 被引用 162 件2017 年: 被引用 234 件2018 年: 被引用 318 件2019 年: 被引用 557 件2020 年: 被引用 854 件2021 年: 被引用 2,165 件2022 年: 被引用 1,799 件2023 年: 被引用 1,455 件2024 年: 被引用 1,993 件2025 年: 被引用 1,106 件2026 年: 被引用 25 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,988 件、この内訳の 29.3%中国: 引用元論文 1,362 件、この内訳の 13.3%ドイツ: 引用元論文 715 件、この内訳の 7%イギリス: 引用元論文 502 件、この内訳の 4.9%カナダ: 引用元論文 369 件、この内訳の 3.6%日本: 引用元論文 347 件、この内訳の 3.4%イタリア: 引用元論文 299 件、この内訳の 2.9%フランス: 引用元論文 263 件、この内訳の 2.6%オーストラリア: 引用元論文 237 件、この内訳の 2.3%韓国: 引用元論文 222 件、この内訳の 2.2%オランダ: 引用元論文 201 件、この内訳の 2%インド: 引用元論文 191 件、この内訳の 1.9%
0%29.3%その他 24.6%

機関

分野

  • Biochemistry, Genetics and Molecular Biology44.5%
  • Medicine36.6%
  • Immunology and Microbiology13.8%
  • Neuroscience1.7%
  • Agricultural and Biological Sciences0.8%
  • Engineering0.7%
  • その他1.9%

トピック

  • RNA Interference and Gene Delivery11.7%
  • SARS-CoV-2 and COVID-19 Research7.7%
  • Immunotherapy and Immune Responses5.5%
  • Advanced biosensing and bioanalysis techniques4.3%
  • Virus-based gene therapy research3.1%
  • COVID-19 Clinical Research Studies2.8%
  • その他64.9%

共著者

全論文

検索で開く
  1. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

    著者: Katalin Karikó, Michael Buckstein, Houping Ni, Drew Weissman - Immunity 2005 被引用: 2,614

  2. mRNA-based therapeutics — developing a new class of drugs

    著者: Uğur Şahin, Katalin Karikó, Özlem Türeci - Nature Reviews Drug Discovery 2014 被引用: 2,420

  3. Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

    著者: Katalin Karikó, Hiromi Muramatsu, Frank A. Welsh, János Ludwig, Hiroki Kato, Shizuo Akira, Drew Weissman - Molecular Therapy 2008 被引用: 1,867

  4. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

    著者: Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini, Katlyn Lederer, Sonia Ndeupen, Chutamath Sittplangkoon, Joel R. Wilmore, Brian T. Gaudette, Ousamah Younoss Soliman, Matthew Pine, Philip Hicks, Tomaz B. Manzoni, James J. Knox, John L. Johnson, Dorottya Laczkó, Hiromi Muramatsu, Benjamin Davis, Wenzhao Meng, Aaron M. Rosenfeld, Shirin Strohmeier, Paulo J.C. Lin, Barbara L. Mui, Ying K. Tam, Katalin Karikó, Alain Jacquet, Florian Krammer, Paul Bates, Michael P. Cancro, Drew Weissman, Eline T. Luning Prak, David Allman, Botond Z. Igyártó, Michela Locci, Norbert Pardi - Immunity 2021 被引用: 723

  5. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

    著者: Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu, Katalin Karikó, Barbara L. Mui, Ying K. Tam, Thomas D. Madden, Michael J. Hope, Drew Weissman - Journal of Controlled Release 2015 被引用: 1,027

  6. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA

    著者: Katalin Karikó, Hiromi Muramatsu, János Ludwig, Drew Weissman - Nucleic Acids Research 2011 被引用: 884

  7. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

    著者: Uğur Şahin, Alexander Muik, Evelyna Derhovanessian, Isabel Vogler, Lena M. Kranz, Mathias Vormehr, Alina Baum, Kristen E. Pascal, Jasmin Quandt, Daniel Maurus, Sebastian Brachtendorf, Verena Lörks, Julian Sikorski, Rolf Hilker, Dirk Becker, Ann-Kathrin Eller, Jan Grützner, Carsten Boesler, Corinna Rosenbaum, Marie-Cristine Kühnle, Ulrich Luxemburger, Alexandra Kemmer-Brück, David Langer, Martin Bexon, Stefanie Bolte, Katalin Karikó, Tania Palanche, Boris Fischer, Armin Schultz, Pei‐Yong Shi, Camila R. Fontes-Garfias, John L. Perez, Kena A. Swanson, Jakob Loschko, Ingrid L. Scully, Mark Cutler, Warren V. Kalina, Christos A. Kyratsous, David Cooper, Philip R. Dormitzer, Kathrin U. Jansen, Özlem Türeci - Nature 2020 被引用: 2,067

  8. A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA

    著者: Markus Baiersdörfer, Gábor Boros, Hiromi Muramatsu, Azita J. Mahiny, Irena Vlatkovic, Uğur Şahin, Katalin Karikó - Molecular Therapy — Nucleic Acids 2019 被引用: 556

  9. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

    著者: Bart R. Anderson, Hiromi Muramatsu, Subba Rao Nallagatla, Philip C. Bevilacqua, Lauren Sansing, Drew Weissman, Katalin Karikó - Nucleic Acids Research 2010 被引用: 676

  10. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis

    著者: Christina Krienke, LAURA D. KOLB, Elif Diken, Michael Streuber, Sarah Kirchhoff, Thomas Bukur, Özlem Akilli‐Öztürk, Lena M. Kranz, Hendrik Berger, Jutta Petschenka, Mustafa Diken, Sebastian Kreiter, Nir Yogev, Ari Waisman, Katalin Karikó, Özlem Türeci, Uğur Şahin - Science 2021 被引用: 486

  11. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine

    著者: Hiromi Muramatsu, Kieu Lam, Csaba Bajusz, Dorottya Laczkó, Katalin Karikó, Petra Schreiner, Alan Martin, Peter Lutwyche, James Heyes, Norbert Pardi - Molecular Therapy 2022 被引用: 310

  12. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

    著者: Norbert Pardi, Michael J. Hogan, Rebecca S. Pelc, Hiromi Muramatsu, Hanné Andersen, Christina R. DeMaso, Kimberly A. Dowd, Laura L. Sutherland, Richard M. Scearce, Robert Parks, Wendeline Wagner, Alex Granados, Jack Greenhouse, Michelle Walker, Elinor Willis, Jae-Sung Yu, Charles E. McGee, Gregory D. Sempowski, Barbara L. Mui, Ying K. Tam, Yan-Jang S. Huang, Dana L. Vanlandingham, Veronica M. Holmes, Harikrishnan Balachandran, Sujata Sahu, Michelle A. Lifton, Stephen Higgs, Scott E. Hensley, Thomas D. Madden, Michael J. Hope, Katalin Karikó, Sampa Santra, Barney S. Graham, Mark G. Lewis, Theodore C. Pierson, Barton F. Haynes, Drew Weissman - Nature 2017 被引用: 894

  13. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

    著者: Norbert Pardi, Michael J. Hogan, Martin S. Naradikian, Kaela Parkhouse, Derek W. Cain, Letitia D. Jones, M. Anthony Moody, Hans Verkerke, Arpita Myles, Elinor Willis, Celia C. LaBranche, David C. Montefiori, Jenna L Lobby, Kevin O. Saunders, Hua‐Xin Liao, Bette Korber, Laura L. Sutherland, Richard M. Scearce, Peter Hraber, István Tombácz, Hiromi Muramatsu, Houping Ni, Daniel A. Balikov, Zhongxia Li, Barbara L. Mui, Ying K. Tam, Florian Krammer, Katalin Karikó, Patricia Polacino, Laurence C. Eisenlohr, Thomas D. Madden, Michael J. Hope, Mark G. Lewis, Kelly K. Lee, Shiu‐Lok Hu, Scott E. Hensley, Michael P. Cancro, Barton F. Haynes, Drew Weissman - The Journal of Experimental Medicine 2018 被引用: 527

  14. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

    著者: Uğur Şahin, Alexander Muik, Isabel Vogler, Evelyna Derhovanessian, Lena M. Kranz, Mathias Vormehr, Jasmin Quandt, Nicole Bidmon, Alexander Ulges, Alina Baum, Kristen E. Pascal, Daniel Maurus, Sebastian Brachtendorf, Verena Lörks, Julian Sikorski, Peter Koch, Rolf Hilker, Dirk Becker, Ann-Kathrin Eller, Jan Grützner, Manuel Tonigold, Carsten Boesler, Corinna Rosenbaum, Ludwig Heesen, Marie-Cristine Kühnle, Asaf Poran, Jesse Z. Dong, Ulrich Luxemburger, Alexandra Kemmer-Brück, David Langer, Martin Bexon, Stefanie Bolte, Tania Palanche, Armin Schultz, Sybille Baumann, Azita J. Mahiny, Gábor Boros, Jonas Reinholz, Gábor Szabó, Katalin Karikó, Pei‐Yong Shi, Camila R. Fontes-Garfias, John L. Perez, Mark Cutler, David Cooper, Christos A. Kyratsous, Philip R. Dormitzer, Kathrin U. Jansen, Özlem Türeci - Nature 2021 被引用: 843

  15. Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models

    著者: C. Hotz, Timothy R. Wagenaar, Friederike Gieseke, Dinesh S. Bangari, Michelle Callahan, Hui Cao, Jan Diekmann, Mustafa Diken, Christian Grunwitz, Andy Hebert, Karl Hsu, Marie Bernardo, Katalin Karikó, Sebastian Kreiter, Andreas N. Kuhn, Mikhail Levit, Natalia V. Malkova, Serena Masciari, Jack Pollard, Hui Qü, Sue Ryan, Abderaouf Selmi, Julia Schlereth, Kuldeep Singh, Fangxian Sun, Bodo Tillmann, Tatiana Tolstykh, William Weber, Lena Wicke, Sonja Witzel, Qunyan Yu, Yuan Zhang, Gang Zheng, Joanne Lager, Gary J. Nabel, Uğur Şahin, Dmitri Wiederschain - Science Translational Medicine 2021 被引用: 206

  16. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice

    著者: Jamile Ramos da Silva, Karine Bitencourt Rodrigues, Guilherme Formoso Pelegrin, Natiely Silva Sales, Hiromi Muramatsu, Mariângela de Oliveira Silva, Bruna F.M.M. Porchia, Ana Carolina Ramos Moreno, Luana R. M. M. Aps, Aléxia Adrianne Venceslau-Carvalho, István Tombácz, Wesley Luzetti Fotoran, Katalin Karikó, Paulo J.C. Lin, Ying K. Tam, Mariana O. Diniz, Norbert Pardi, Luís Carlos de Souza Ferreira - Science Translational Medicine 2023 被引用: 140

  17. mRNA Is an Endogenous Ligand for Toll-like Receptor 3

    著者: Katalin Karikó, Houping Ni, John Capodici, Marc S. Lamphier, Drew Weissman - Journal of Biological Chemistry 2004 被引用: 1,048

  18. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

    著者: Dorottya Laczkó, Michael J. Hogan, Sushila A. Toulmin, Philip Hicks, Katlyn Lederer, Brian T. Gaudette, Diana Castaño, Fatima Amanat, Hiromi Muramatsu, Thomas H. Oguin, Amrita Ojha, Lizhou Zhang, Zekun Mu, Robert Parks, Tomaz B. Manzoni, Brianne Roper, Shirin Strohmeier, István Tombácz, Leslee Arwood, Raffael Nachbagauer, Katalin Karikó, Jack Greenhouse, Laurent Pessaint, Maciel Porto, Tammy Taylor, Amanda Strasbaugh, Tracey-Ann Campbell, Paulo J.C. Lin, Ying K. Tam, Gregory D. Sempowski, Michael Farzan, Hyeryun Choe, Kevin O. Saunders, Barton F. Haynes, Hanné Andersen, Laurence C. Eisenlohr, Drew Weissman, Florian Krammer, Paul Bates, David Allman, Michela Locci, Norbert Pardi - Immunity 2020 被引用: 389

  19. Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

    著者: Norbert Pardi, Kaela Parkhouse, Ericka Kirkpatrick, Meagan McMahon, Seth J. Zost, Barbara L. Mui, Ying K. Tam, Katalin Karikó, Christopher Barbosa, Thomas D. Madden, Michael J. Hope, Florian Krammer, Scott E. Hensley, Drew Weissman - Nature Communications 2018 被引用: 285

  20. Elimination of large tumors in mice by mRNA-encoded bispecific antibodies

    著者: Christiane Stadler, Hayat Bähr-Mahmud, Leyla Çelik, Bernhard Hebich, Alexandra S Roth, René P Roth, Katalin Karikó, Özlem Türeci, Uğur Şahin - Nature Medicine 2017 被引用: 277

  21. Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L

    著者: Bart R. Anderson, Hiromi Muramatsu, Babal K. Jha, Robert H. Silverman, Drew Weissman, Katalin Karikó - Nucleic Acids Research 2011 被引用: 345

  22. In Vitro Transcription of Long RNA Containing Modified Nucleosides

    著者: Norbert Pardi, Hiromi Muramatsu, Drew Weissman, Katalin Karikó - Methods in molecular biology 2012 被引用: 208

  23. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

    著者: Norbert Pardi, Anthony Secreto, Xiaochuan Shan, Fotini Debonera, Joshua Glover, Yanjie Yi, Hiromi Muramatsu, Houping Ni, Barbara L. Mui, Ying K. Tam, Farida Shaheen, Ronald G. Collman, Katalin Karikó, Gwenn Danet-Desnoyers, Thomas D. Madden, Michael J. Hope, Drew Weissman - Nature Communications 2017 被引用: 347

  24. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

    著者: Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini, Katlyn Lederer, Chutamath Sittplangkoon, Joel R. Wilmore, Brian T. Gaudette, Ousamah Younoss Soliman, Matthew Pine, Philip Hicks, Tomaz B. Manzoni, James J. Knox, John L. Johnson, Dorottya Laczkó, Hiromi Muramatsu, Benjamin G. Davis, Wenzhao Meng, Aaron M. Rosenfeld, Shirin Strohmeier, Paulo J.C. Lin, Barbara L. Mui, Ying K. Tam, Katalin Karikó, Alain Jacquet, Florian Krammer, Paul Bates, Michael P. Cancro, Drew Weissman, Eline T. Luning Prak, David Allman, Michela Locci, Norbert Pardi - Immunity 2022 被引用: 77